RCLY vs. ARKG

Last updated Jul 10, 2026

RCLY (Reckoner BBB-B CLO Annual ETF) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both exchange-traded funds - RCLY is a Actively Managed fund actively managed by Reckoner, while ARKG is a Health & Biotech Equities fund actively managed by ARK. Both are actively managed. At a 0.14 correlation, their price movements are largely independent. RCLY charges 0.55%/yr vs 0.75%/yr for ARKG.

Performance

RCLY vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Reckoner BBB-B CLO Annual ETF (RCLY) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

RCLY

• 1D: -0.07%
• 1M: 0.21%
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

ARKG

• 1D: 2.70%
• 1M: 28.13%
• 6M: 39.11%
• YTD: 48.43%
• 1Y: 64.94%
• 3Y*: 7.24%
• 5Y*: -13.62%
• 10Y*: 9.86%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RCLY vs. ARKG - Yearly Performance Comparison

	2026 (YTD)
RCLY Reckoner BBB-B CLO Annual ETF	1.09%
ARKG ARK Genomic Revolution Multi-Sector ETF	47.61%

Correlation

The correlation between RCLY and ARKG is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Feb 11, 2026	0.14

Return for Risk

RCLY vs. ARKG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RCLY

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

ARKG

ARKG Risk / Return Rank: 53
ARKG Sharpe Ratio Rank: 56
ARKG Sortino Ratio Rank: 59
ARKG Omega Ratio Rank: 49
ARKG Calmar Ratio Rank: 60
ARKG Martin Ratio Rank: 43

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RCLY vs. ARKG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Reckoner BBB-B CLO Annual ETF (RCLY) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	RCLY	ARKG	Difference
Sharpe ratio: Return per unit of total volatility	—	1.52	—
Sortino ratio: Return per unit of downside risk	—	2.22	—
Omega ratio: Gain probability vs. loss probability	—	1.25	—
Calmar ratio: Return relative to maximum drawdown	—	2.37	—
Martin ratio: Return relative to average drawdown	—	5.65	—

Drawdowns

RCLY vs. ARKG - Drawdown Comparison

The maximum RCLY drawdown since its inception was -3.69%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for RCLY and ARKG.

Drawdown Indicators

	RCLY	ARKG	Difference
Max Drawdown Largest peak-to-trough decline	-3.69%	-83.59%	+79.90%
Max Drawdown (1Y) Largest decline over 1 year	—	-27.51%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-51.96%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-79.49%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-83.59%	—
Current Drawdown Current decline from peak	-0.07%	-61.53%	+61.46%
Average Drawdown Average peak-to-trough decline	-0.77%	-36.11%	+35.34%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	11.53%	—

Volatility

Volatility by Period

	RCLY	ARKG	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	11.67%	—
Volatility (6M) Calculated over the trailing 6-month period	—	31.52%	—
Volatility (1Y) Calculated over the trailing 1-year period	3.69%	43.05%	-39.36%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	3.69%	46.11%	-42.42%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	3.69%	41.36%	-37.67%

RCLY vs. ARKG - Expense Ratio Comparison

RCLY has a 0.55% expense ratio, which is lower than ARKG's 0.75% expense ratio.

Dividends

RCLY vs. ARKG - Dividend Comparison

Neither RCLY nor ARKG has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
ARKG ARK Genomic Revolution Multi-Sector ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.62%	0.85%	3.14%	0.82%	1.34%
RCLY Reckoner BBB-B CLO Annual ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both RCLY and ARKG in my portfolio?

RCLY and ARKG have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, RCLY or ARKG?

On fees, RCLY is cheaper at 0.55% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, RCLY or ARKG?

RCLY is cheaper with a 0.55% expense ratio, compared with 0.75% for ARKG.

Which ETF pays a higher dividend yield, RCLY or ARKG?

RCLY and ARKG have nearly identical dividend yields, around 0.00%.

What is the main difference between RCLY and ARKG?

RCLY is categorized as Actively Managed, while ARKG is Health & Biotech Equities. They also come from different issuers: Reckoner and ARK. Their fees differ too: 0.55% for RCLY and 0.75% for ARKG.